Chenodeoxycholic Acid
Sponsors
National Center for Research Resources (NCRR), University of Cincinnati, US Department of Veterans Affairs, University Hospital, Basel, Switzerland, University Hospital, Gentofte, Copenhagen
Conditions
AdrenoleukodystrophyBifunctional Enzyme DeficiencyBile Acid MalabsorptionCerebrotendinous XanthomatosesCerebrotendinous XanthomatosisCholelithiasisFamilial Combined HyperlipidemiaFamilial Hypertriglyceridemia
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass
CompletedNCT02340247
Start: 2014-11-30Updated: 2016-06-30
Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
CompletedNCT02876484
Start: 2016-06-30End: 2020-11-30Updated: 2020-11-30
Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric Bypass
CompletedNCT02952963
Start: 2016-10-31End: 2020-11-30Updated: 2020-11-30
Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy
CompletedNCT03168555
Start: 2017-06-22End: 2019-05-15Updated: 2022-05-19
Unknown Phase
Study of Bile Acids in Patients With Peroxisomal Disorders
TerminatedNCT00004442
End: 1999-04-30Target: 25Updated: 2015-03-25
Cholestanol in Humans
WithdrawnNCT00018694
Start: 1999-10-31End: 2009-12-31Updated: 2013-10-14
Effect of Bile Acids on GLP-1 Secretion
CompletedNCT01666223
Start: 2012-11-30End: 2013-06-30Updated: 2013-12-24
Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX)
CompletedNCT05499026
Start: 2014-12-09End: 2015-06-03Updated: 2022-08-12